Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
April/May 2023
February/March 2023
December 2022/January 2023
October/November 2022
Newsletters
Podcasts
More
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SEARCH
SIGN IN
Subscribe Now
Biotech
Newsletters
Can an A.I. algorithm spot the next Facebook or Uber? The founder of this European VC firm thinks so
BY
Lucy Brewster
May 24, 2023
Newsletters
A.I.-fueled biotech startups are having a moment—and one just raised $300 million in a Series A
BY
Lucy Brewster
May 23, 2023
Health
How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own
BY
Arthur Allen
and
KFF Health News
April 13, 2023
Tech
The Silicon Valley Bank meltdown could be a disaster for downtrodden biotech startups
BY
Angelica Peebles
,
Ilena Peng
, and others
March 10, 2023
Tech
The 11 most promising health tech startups, according to Silicon Valley VCs
BY
Lucy Brewster
October 24, 2022
Tech
Health Tech startups are booming. These 11 VC investors are behind some of the hottest deals
BY
Lucy Brewster
September 23, 2022
Finance
Biden’s new executive order triggers new front in U.S.-China economic competition
BY
Tristan Bove
September 12, 2022
Asia
Biden to spur biomanufacturing, reduce reliance on China with executive order
BY
Riley Griffin
and
Bloomberg
September 10, 2022
Health
Parents are becoming drug developers to find a cure for their children’s rare diseases
BY
Jared Whitlock
and
Kaiser Health News
July 21, 2022
Commentary
ESG investors shouldn’t ignore biotech’s potential to deliver change
BY
Michelle McMurry-Heath
May 2, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
BY
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Finance
Investors are moving away from biotech stocks as COVID wanes
BY
Angelica Peebles
and
Bloomberg
February 14, 2022
Health
Sanofi agrees to partnership with A.I.-based drug discovery company Exscientia worth up to $5.2 billion
BY
Jeremy Kahn
January 7, 2022
Health
Omicron vaccine to begin clinical trial in South Africa
BY
Jeremy Kahn
December 6, 2021
Magazine
Moderna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
BY
Rey Mashayekhi
December 2, 2021
Load More
Most Popular
Success
Tina Turner renounced her American citizenship for the country that gave her a ‘completely normal life’: Switzerland
May 25, 2023
BY
Boris Heger
,
Arnd Wiegmann
, and others
Finance
Democratic veterans from 2 decades of budget wars say the national debt isn’t worth holding the U.S. and global economy...
May 27, 2023
BY
Tristan Bove
Finance
High-school sweethearts with good jobs, a baby on the way and a $600,000 budget can’t find a house after 2 years of...
May 27, 2023
BY
Alena Botros